Lesions
AI may help predict patient response to non-small cell lung cancer therapies
March 23, 2020Medical Communications, Sales and Marketing Cancer, Lesions, cancer treatment, tumour treatment
Researchers have used artificial intelligence to train algorithms to predict tumour sensitivity to systemic cancer therapies. Radiologists previously determined if …
Ameluz approved by European Commission for treatment for actinic keratosis
March 11, 2020Research and Development EC, EMA, Europe, Lesions
Biofrontera AG has announced the European Commission has approved the use of their drug Ameluz in combination with photodynamic therapy …
Latest content
The evidence bar impacting UK medical cannabis access
November 6, 2026
Addressing the rheumatic disease diagnostic gap in primary care
November 5, 2026
